SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.

Autor: Wang, Mengchao1 (AUTHOR), Wang, Zhiheng1 (AUTHOR), Zhi, Xiaosong1,2,3 (AUTHOR), Ding, Wenbin1 (AUTHOR), Xiong, Jun4 (AUTHOR), Tao, Tian1 (AUTHOR), Yang, Yun1 (AUTHOR), Zhang, Hongxia2 (AUTHOR), Zi, Xiaoyuan1,2 (AUTHOR) zi_xiaoyuan@163.com, Zhou, Weiping1 (AUTHOR) ehphwp@126.com, Huang, Gang1 (AUTHOR) squaror@163.com
Zdroj: Biomedicine & Pharmacotherapy. Sep2020, Vol. 129, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: